Cargando…
miR-34 modulates apoptotic gene expression in Ingenol mebutate treated keloid fibroblasts
Keloids are benign skin tumors that develop in individuals who have a positive family history of keloid disorders. Keloids are characterized by a deregulated wound-healing process, atypical fibroblasts with extreme deposition of extracellular matrix components, particularly collagen, increased cell...
Autores principales: | De Felice, Bruna, Manfellotto, Francesco, Garbi, Corrado, Santoriello, Margherita, Nacca, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928664/ https://www.ncbi.nlm.nih.gov/pubmed/29568916 http://dx.doi.org/10.3892/mmr.2018.8749 |
Ejemplares similares
-
Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015) -
Tattoo removal with ingenol mebutate
por: Cozzi, Sarah-Jane, et al.
Publicado: (2017) -
The Role of Ingenol Mebutate in the Treatment of Actinic Keratoses
por: Ali, Faisal R., et al.
Publicado: (2012) -
Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate
por: Mansuy, Marion, et al.
Publicado: (2014) -
Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013)